Market Cap | 141.08M | P/E | - | EPS this Y | 25.70% | Ern Qtrly Grth | - |
Income | -26.6M | Forward P/E | -42.10 | EPS next Y | 92.30% | 50D Avg Chg | 20.00% |
Sales | 178.28M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 82.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -23.00% |
Recommedations | 1.90 | Quick Ratio | 0.80 | Shares Outstanding | 43.07M | 52W Low Chg | 269.00% |
Insider Own | 15.57% | ROA | -24.20% | Shares Float | 35.69M | Beta | 1.19 |
Inst Own | 38.40% | ROE | - | Shares Shorted/Prior | 4.70M/4.59M | Price | 4.21 |
Gross Margin | 88.92% | Profit Margin | -13.18% | Avg. Volume | 358,162 | Target Price | 12.57 |
Oper. Margin | -12.45% | Earnings Date | Nov 6 | Volume | 141,569 | Change | -5.39% |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
Cantor Fitzgerald | Overweight | Sep 20, 24 |
Cantor Fitzgerald | Overweight | Aug 20, 24 |
Cantor Fitzgerald | Overweight | Aug 9, 24 |
Keybanc | Overweight | Jul 11, 24 |
Keybanc | Overweight | Jun 5, 24 |
B. Riley Securities | Buy | May 21, 24 |
HC Wainwright & Co. | Buy | May 10, 24 |
Cantor Fitzgerald | Overweight | May 9, 24 |
BTIG | Buy | Apr 23, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Jindal Piyush | Director Director | Nov 06 | Option | 2.52 | 37,500 | 94,500 | 337,500 | 11/08/23 |
Velge Bertrand | Director Director | Jun 07 | Buy | 2.41 | 73,965 | 178,256 | 213,465 | 09/01/23 |
Velge Bertrand | Director Director | Nov 02 | Buy | 3.76 | 132,072 | 496,591 | 349,482 | 08/31/23 |
Alvarez Nicholas P | Chief Acquisition Of.. Chief Acquisition Officer | Jun 14 | Buy | 2.92 | 10,712 | 31,279 | 180,000 | 06/15/23 |
Yecies Eric Harold | General Counsel & CC.. General Counsel & CCO | Jun 13 | Buy | 2.6 | 11,500 | 29,900 | 62,500 | 06/14/23 |
Velge Bertrand | Director Director | Jun 05 | Buy | 2.17 | 139,500 | 302,715 | 139,500 | 06/07/23 |
Galluppi Stefan | Chief Innovation Off.. Chief Innovation Officer | May 23 | Buy | 2.17 | 4,608 | 9,999 | 12,449 | 05/31/23 |
Schreiber Justin | CEO CEO | May 22 | Buy | 2.11 | 50,000 | 105,500 | 2,844,620 | 05/24/23 |
DiTrolio Joseph | Director Director | Mar 10 | Buy | 3.28 | 2,000 | 6,560 | 24,500 | 03/11/22 |
Benathen Marc David | Chief Financial Offi.. Chief Financial Officer | Aug 18 | Buy | 7.29 | 3,067 | 22,358 | 19,723 | 08/18/21 |